BE835823A - Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie - Google Patents

Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie

Info

Publication number
BE835823A
BE835823A BE162080A BE162080A BE835823A BE 835823 A BE835823 A BE 835823A BE 162080 A BE162080 A BE 162080A BE 162080 A BE162080 A BE 162080A BE 835823 A BE835823 A BE 835823A
Authority
BE
Belgium
Prior art keywords
hyperlipidemia
compositions
production
activity
new
Prior art date
Application number
BE162080A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE835823A publication Critical patent/BE835823A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE162080A 1974-11-27 1975-11-21 Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie BE835823A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (1)

Publication Number Publication Date
BE835823A true BE835823A (fr) 1976-05-21

Family

ID=24101958

Family Applications (1)

Application Number Title Priority Date Filing Date
BE162080A BE835823A (fr) 1974-11-27 1975-11-21 Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie

Country Status (10)

Country Link
US (1) US3969508A (US08177716-20120515-C00003.png)
AU (1) AU499316B2 (US08177716-20120515-C00003.png)
BE (1) BE835823A (US08177716-20120515-C00003.png)
DE (1) DE2553101A1 (US08177716-20120515-C00003.png)
FR (1) FR2292470A1 (US08177716-20120515-C00003.png)
GB (1) GB1535203A (US08177716-20120515-C00003.png)
IL (1) IL48518A (US08177716-20120515-C00003.png)
NL (1) NL7513877A (US08177716-20120515-C00003.png)
PH (2) PH11295A (US08177716-20120515-C00003.png)
ZA (1) ZA757439B (US08177716-20120515-C00003.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (US08177716-20120515-C00003.png) * 1968-05-20 1971-04-15
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Also Published As

Publication number Publication date
NL7513877A (nl) 1976-05-31
FR2292470A1 (fr) 1976-06-25
PH12855A (en) 1979-09-12
ZA757439B (en) 1976-11-24
PH11295A (en) 1977-11-02
IL48518A0 (en) 1976-01-30
AU499316B2 (en) 1979-04-12
GB1535203A (en) 1978-12-13
DE2553101A1 (de) 1976-08-12
US3969508A (en) 1976-07-13
IL48518A (en) 1978-08-31
FR2292470B1 (US08177716-20120515-C00003.png) 1978-11-10
AU8689475A (en) 1977-06-02

Similar Documents

Publication Publication Date Title
BE836528A (fr) Nouveaux derives d'acide 3-amino- indazolecarboxylique
FR2301497A1 (fr) Composition d'engrais
IT1061384B (it) Composizione catalitica e relativi metodi di preparazione e di impiego
FR2278335A1 (fr) Derives d'azetidinones et leurs procedes de preparation
TR19461A (tr) Polimerik koepuek imalinde veya bununla ilgili islahat
FR2316942A1 (fr) Derives halo-substitues d'acide 1-(alcoyl) inferieur -5-aroylpyrrole-2-acetique
IT1050554B (it) Procedimento di delignificazione e sbianca di pastalegno mediante ossigeno
FR2335204A1 (fr) Nouvelles formulations de niclosamide en suspension
FR2275437A1 (fr) Production catalytique de l'acide hydroxy-acetique et de l'acide oxy-diacetique
BE824889A (fr) Alliage de plomb et d'antimoine
BE880443A (fr) Procedes et composition catalytiques d'hydroformylation et d'hydrohydroxymethylation
BE824246A (fr) Production catalytique d'halogenures organostanniques
FR2276364A1 (fr) Nouvelles compositions d'azido-silanes et leur procede d'application
FR2291983A1 (fr) Purification de l'urokinase
BE829344A (fr) Preparation de l'alpha-6-desocy-5- hydroxytetracycline
BE836559A (fr) Compositions desinfectantes d'oxydiacetaldehyde
BE854908A (fr) Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant
BE852557A (fr) Preparation de nouvelles isobutyramides
FR2302102A1 (fr) Nouvelles substances antibiotiques derivees de l'antibiotique 67-694 et leurs procedes de preparation
BE835823A (fr) Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie
BE825437A (fr) Compositions analgesiques douees d'une activite therapeutique amelioree
BE851490R (fr) Nouvelles compositions anti-hyperlipidemie et methode de production d'une activite anti-hyperlipidemie
FR2278797A1 (fr) Preparation electrochimique d'esters aromatiques
FR2319351A1 (fr) Hydantoines et procedes d'obtention
BE833260A (fr) Solution de nouveaux complexes d'antimoine

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITHKLINE CORP.

Effective date: 19851130